Filing Details

Accession Number:
0001127602-21-011821
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-03-23 16:19:42
Reporting Period:
2021-03-22
Accepted Time:
2021-03-23 16:19:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1682852 Moderna Inc. MRNA Biological Products, (No Disgnostic Substances) (2836) 813467528
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1690927 Zvi Tal Zaks C/O Moderna, Inc.
200 Technology Square
Cambridge MA 02139
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-03-22 1,199 $20.93 1,199 No 4 M Direct
Common Stock Disposition 2021-03-22 255 $142.83 944 No 4 S Direct
Common Stock Disposition 2021-03-22 366 $144.06 578 No 4 S Direct
Common Stock Disposition 2021-03-22 227 $145.47 351 No 4 S Direct
Common Stock Disposition 2021-03-22 290 $146.46 61 No 4 S Direct
Common Stock Disposition 2021-03-22 61 $147.50 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2021-03-22 1,199 $0.00 1,199 $20.93
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
169,599 2029-03-08 No 4 M Direct
Footnotes
  1. The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020.
  2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $142.23 to $143.22. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $143.63 to $144.60. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  4. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $144.89 to $145.85. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  5. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $146.15 to $146.95. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  6. 25% of this option vested and became exercisable on March 8, 2020 with the remainder vesting in 12 equal quarterly installments thereafter.